awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45893661-2491D5F2-E1CA-4932-BE20-292FDD7DAAC8
Q45893661-2491D5F2-E1CA-4932-BE20-292FDD7DAAC8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45893661-2491D5F2-E1CA-4932-BE20-292FDD7DAAC8
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective.
P2860
Q45893661-2491D5F2-E1CA-4932-BE20-292FDD7DAAC8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45893661-2491D5F2-E1CA-4932-BE20-292FDD7DAAC8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2de976a1e7eec67210e50a353f5e436c1da37daf
P2860
Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial.